Also available in Persian — نسخه فارسی EN فا
❓ Unknown

Significant Growth in Iran's Pharmaceutical Raw Materials Industry / Domestic Production of 700 Out of 900 Global Active Ingredients

3d ago September 13, 2026 1 min read 📰 ISNA
📋 Key Takeaway

Iran has made significant strides in its pharmaceutical industry by producing around 700 active ingredients domestically. This achievement is attributed to the collaboration between scientific and industrial sectors and is seen as a point of national pride.

🔍 Quick Context Guide
💡 Bottom Line: Iran's production of 700 active pharmaceutical ingredients signifies a major step towards self-reliance in healthcare amid economic challenges.

👥 Key Players

Syndicate of Pharmaceutical, Chemical, and Packaging Raw Material Producers MENTIONED
Industry representative body
"They play a crucial role in advocating for the pharmaceutical sector and facilitating collaboration between scientific and industrial institutions in Iran."

📰 What Happened

Iran has achieved the production of approximately 700 out of the 900 active pharmaceutical ingredients available globally, marking a significant advancement in its pharmaceutical industry. This achievement is celebrated as a result of effective collaboration between scientific and industrial sectors.

  • Iran produces around 700 active pharmaceutical ingredients domestically.
  • This accomplishment is seen as a source of national pride and reflects improvements in pharmaceutical infrastructure.

💡 Why It Matters

🇮🇷 For Iran: This achievement enhances Iran's self-sufficiency in healthcare and reduces reliance on imported pharmaceuticals, which is vital given ongoing sanctions.
🌍 Regional: It may influence regional pharmaceutical markets by positioning Iran as a potential supplier of active ingredients.
🌐 International: This development could raise concerns among Western nations regarding Iran's capabilities and self-sufficiency in critical sectors.

📚 Background

Iran has been working to bolster its domestic industries, particularly in pharmaceuticals, as a response to international sanctions that limit access to foreign goods. This initiative is part of a broader strategy to achieve economic independence.

Economic sanctions on Iran Iran's healthcare system
📡 Source: STATE MEDIA
📊 Confidence: 70%
The information is likely presented positively to highlight national achievements, but may lack critical perspectives on challenges faced by the industry.

The head of the Syndicate of Pharmaceutical, Chemical, and Packaging Raw Material Producers highlighted the country's achievements in pharmaceutical infrastructure, stating that Iran has succeeded in producing approximately 700 out of the 900 active pharmaceutical ingredients available globally. He regarded this success as a source of national pride and a result of collaboration between scientific and industrial institutions.

🌐

Translated from the original and edited for English readers. View original source →

Translation confidence: 85%

📰 Related Coverage

⚖️ Independent Platform — Artesh.com is not affiliated with any government, military, or political organization. Editorial Policy →